PDCD4 functions as a suppressor for pT2a and pT2b stage gastric cancer

By        

Oncology Reports, Vol. 29, Iss. 3, 2013-01 ,pp. : 1007-1012

Spandidos Publications

Access to resources Recommend Favorite

Clinical impact of systematic pelvic and para-aortic lymphadenectomy for pT1 and pT2 ovarian cancer: a retrospective survey by the Sankai Gynecology Study Group

By Oshita Takafumi   Itamochi Hiroaki   Nishimura Ryuichiro   Numa Fumitaka   Takehara Kazuhiro   Hiura Masamichi   Tanimoto Hirotoshi   Noma Jun   Hayase Ryoji   Murakami Akihiro   Fujimoto Hideo   Kanamori Yasunobu   Kitada Fuminori   Shitsukawa Keiji   Nagaji Makoto   Minagawa Yukihisa   Fujiwara Michihisa   Kigawa Junzo  

International Journal of Clinical Oncology, Vol. 18, Iss. 6, 2013-12 ,pp. : 1107-1113

Springer Publishing Company

Access to resources Recommend Favorite

Should adjuvant trastuzumab be offered in very early-stage (pT1a/bN0M0) HER2- neu -positive breast cancer? A current debate

By Petrelli Fausto  

Medical Oncology, Vol. 28, Iss. 2, 2011-06 ,pp. : 401-408

Humana Press, Inc

Access to resources Recommend Favorite

Prognostic Significance of Lymph Node Metastasis and Clear Cell Histology in Ovarian Carcinoma Limited to the Pelvis (pT1M0 and pT2M0)

By Sakuragi N.   Yamada H.   Oikawa M.   Okuyama K.   Fujino T.   Sagawa T.   Fujimoto S.  

Gynecologic Oncology, Vol. 79, Iss. 2, 2000-11 ,pp. : 251-255

Elsevier

Access to resources Recommend Favorite

Expression of immunoglobulin-like transcript (ILT)2 and ILT3 in human gastric cancer and its clinical significance

By                  

Molecular Medicine Reports, Vol. 5, Iss. 4, 2012-01 ,pp. : 910-916

Spandidos Publications

Access to resources Recommend Favorite